» Articles » PMID: 39596261

Oxidative Stress and Placental Pathogenesis: A Contemporary Overview of Potential Biomarkers and Emerging Therapeutics

Abstract

Oxidative stress (OS) plays a crucial role in placental pathogenesis and pregnancy-related complications. This review explores OS's impact on placental development and function, focusing on novel biomarkers for the early detection of at-risk pregnancies and emerging therapeutic strategies. We analyzed recent research on OS in placental pathophysiology, examining its sources, mechanisms, and effects. While trophoblast invasion under low-oxygen conditions and hypoxia-induced OS regulate physiological placental development, excessive OS can lead to complications like miscarriage, preeclampsia, and intrauterine growth restriction. Promising OS biomarkers, including malondialdehyde, 8-isoprostane, and the sFlt-1/PlGF ratio, show potential for the early detection of pregnancy complications. Therapeutic strategies targeting OS, such as mitochondria-targeted antioxidants, Nrf2 activators, and gasotransmitter therapies, demonstrate encouraging preclinical results. However, clinical translation remains challenging. Future research should focus on validating these biomarkers in large-scale studies and developing personalized therapies to modulate placental OS. Emerging approaches like extracellular vesicle-based therapies and nanomedicine warrant further investigation for both diagnostic and therapeutic applications in pregnancy-related complications. Integrating OS biomarkers with other molecular and cellular markers offers improved potential for the early identification of at-risk pregnancies.

Citing Articles

Oxidative Stress Induced by Antivirals: Implications for Adverse Outcomes During Pregnancy and in Newborns.

Costa B, Gouveia M, Vale N Antioxidants (Basel). 2025; 13(12.

PMID: 39765846 PMC: 11727424. DOI: 10.3390/antiox13121518.

References
1.
Biron-Shental T, Sukenik-Halevy R, Sharon Y, Goldberg-Bittman L, Kidron D, Fejgin M . Short telomeres may play a role in placental dysfunction in preeclampsia and intrauterine growth restriction. Am J Obstet Gynecol. 2010; 202(4):381.e1-7. DOI: 10.1016/j.ajog.2010.01.036. View

2.
Syngelaki A, Nicolaides K, Balani J, Hyer S, Akolekar R, Kotecha R . Metformin versus Placebo in Obese Pregnant Women without Diabetes Mellitus. N Engl J Med. 2016; 374(5):434-43. DOI: 10.1056/NEJMoa1509819. View

3.
Kaufmann P . Basic morphology of the fetal and maternal circuits in the human placenta. Contrib Gynecol Obstet. 1985; 13:5-17. View

4.
Burton G, Jauniaux E . Placental oxidative stress: from miscarriage to preeclampsia. J Soc Gynecol Investig. 2004; 11(6):342-52. DOI: 10.1016/j.jsgi.2004.03.003. View

5.
Zhang K . Integration of ER stress, oxidative stress and the inflammatory response in health and disease. Int J Clin Exp Med. 2010; 3(1):33-40. PMC: 2848304. View